Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure.

We have previously shown that the calcium-calmodulin-regulated phosphatase calcineurin (PP2B) is sufficient to induce cardiac hypertrophy that transitions to heart failure in transgenic mice. Given the rapid onset of heart failure in these mice, we hypothesized that calcineurin signaling would stimulate myocardial cell apoptosis. However, utilizing multiple approaches, we determined that calcineurin-mediated hypertrophy protected cardiac myocytes from apoptosis, suggesting a model of heart failure that is independent of apoptosis. Adenovirally mediated gene transfer of a constitutively active calcineurin cDNA (AdCnA) was performed in cultured neonatal rat cardiomyocytes to elucidate the mechanism whereby calcineurin affected myocardial cell viability. AdCnA infection, which induced myocyte hypertrophy and atrial natriuretic factor expression, protected against apoptosis induced by 2-deoxyglucose or staurosporine, as assessed by terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) labeling, caspase-3 activation, DNA laddering, and cellular morphology. The level of protection conferred by AdCnA was similar to that of adenoviral Bcl-x(L) gene transfer or hypertrophy induced by phenylephrine. In vivo, failing hearts from calcineurin-transgenic mice did not demonstrate increased TUNEL labeling and, in fact, demonstrated a resistance to ischemia/reperfusion-induced apoptosis. We determined that the mechanism whereby calcineurin afforded protection from apoptosis was partially mediated by nuclear factor of activated T cells (NFAT3) signaling and partially by Akt/protein kinase B (PKB) signaling. Although calcineurin activation protected myocytes from apoptosis, inhibition of calcineurin with cyclosporine was not sufficient to induce TUNEL labeling in Gqalpha-transgenic mice or in cultured cardiomyocytes. Collectively, these data identify a calcineurin-dependent mouse model of dilated heart failure that is independent of apoptosis.

[1]  Q. Li,et al.  Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. , 1998, The Journal of clinical investigation.

[2]  J. Romashkova,et al.  NF-κB is a target of AKT in anti-apoptotic PDGF signalling , 1999, Nature.

[3]  S. Dudek,et al.  Select Alterations in Protein Kinases and Phosphatases During Apoptosis of Differentiated PC12 Cells , 1997, Journal of neurochemistry.

[4]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[5]  Lei Wang,et al.  Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. , 1998, Circulation research.

[6]  M Crompton,et al.  The mitochondrial permeability transition pore and its role in cell death. , 1999, The Biochemical journal.

[7]  Y. Tozawa,et al.  Calcineurin activation protects T cells from glucocorticoid-induced apoptosis. , 1995, Journal of immunology.

[8]  Q. Li,et al.  Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. , 1997, The Journal of clinical investigation.

[9]  J Ross,et al.  Cardiac Muscle Cell Hypertrophy and Apoptosis Induced by Distinct Members of the p38 Mitogen-activated Protein Kinase Family* , 1998, The Journal of Biological Chemistry.

[10]  J. Lord,et al.  Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)‐mediated apoptosis in activation‐induced T cell death involves calcineurin and protein kinase C, respectively , 1999, European journal of immunology.

[11]  F. Brosius,et al.  Glucose Uptake and Glycolysis Reduce Hypoxia-induced Apoptosis in Cultured Neonatal Rat Cardiac Myocytes* , 1999, The Journal of Biological Chemistry.

[12]  J. Molkentin,et al.  Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[13]  W. Fiers,et al.  Differential role of calcium in tumour necrosis factor-mediated apoptosis and secretion of granulocyte-macrophage colony-stimulating factor in a T cell hybridoma. , 1997, Cytokine.

[14]  R. Kitsis,et al.  The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. , 1999, Circulation research.

[15]  T. Yue,et al.  Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3. , 1998, Journal of molecular and cellular cardiology.

[16]  S. Orrenius,et al.  Calcineurin and mitochondrial function in glutamate‐induced neuronal cell death , 1996, FEBS letters.

[17]  P. Anversa,et al.  Acute myocardial infarction leads to upregulation of the IGF-1 autocrine system, DNA replication, and nuclear mitotic division in the remaining viable cardiac myocytes. , 1994, Experimental cell research.

[18]  A. Koretsky,et al.  Dilated Cardiomyopathy in Transgenic Mice With Cardiac-Specific Overexpression of Tumor Necrosis Factor-α , 1997 .

[19]  B. Trapnell,et al.  Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy , 1996, Journal of virology.

[20]  M. Mehra,et al.  Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine , 1997, Current opinion in cardiology.

[21]  Jeffrey Robbins,et al.  A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy , 1998, Cell.

[22]  S. Vatner,et al.  Apoptosis of Cardiac Myocytes in Gsα Transgenic Mice , 1999 .

[23]  John W. Adams,et al.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Webster,et al.  Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x. , 1999, Circulation research.

[25]  H. Ikeda,et al.  DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. , 1995, The American journal of pathology.

[26]  S. Snyder,et al.  Cain, A Novel Physiologic Protein Inhibitor of Calcineurin* , 1998, The Journal of Biological Chemistry.

[27]  A. Borczuk,et al.  β-Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. , 1998, American journal of physiology. Heart and circulatory physiology.

[28]  John Calvin Reed,et al.  Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.

[29]  L. Peso,et al.  Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.

[30]  R. Kitsis,et al.  Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. , 1997, The Journal of clinical investigation.

[31]  P. Claudio,et al.  Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. , 1999, The American journal of pathology.

[32]  N. Bishopric,et al.  Atrial Natriuretic Peptide Induces Apoptosis in Neonatal Rat Cardiac Myocytes* , 1997, The Journal of Biological Chemistry.

[33]  S. Kondo,et al.  Induction of Thymocyte Apoptosis by Ca2+-independent Protein Kinase C (nPKC) Activation and Its Regulation by Calcineurin Activation* , 1998, The Journal of Biological Chemistry.

[34]  A. Borczuk,et al.  beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. , 1998, The American journal of physiology.

[35]  P. Halloran,et al.  Quantitating immunosuppression. Estimating the 50% inhibitory concentration for in vivo cyclosporine in mice. , 1996, Transplantation.

[36]  W. MacLellan,et al.  Death by design. Programmed cell death in cardiovascular biology and disease. , 1997, Circulation research.

[37]  S. Izumo,et al.  Apoptosis: basic mechanisms and implications for cardiovascular disease. , 1998, Circulation research.

[38]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[39]  K. Chien,et al.  Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent Pathway , 1997, The Journal of Biological Chemistry.

[40]  R. Peshock,et al.  Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. , 1998, Circulation.

[41]  H. Youn,et al.  Cabin 1, a negative regulator for calcineurin signaling in T lymphocytes. , 1998, Immunity.

[42]  J. Lotem,et al.  Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  R. Reneman,et al.  Cloning and cellular distribution of a group II phospholipase A2 expressed in the heart. , 1997, Journal of molecular and cellular cardiology.

[44]  J. Lotem,et al.  Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Zechner,et al.  MKK6 Activates Myocardial Cell NF-κB and Inhibits Apoptosis in a p38 Mitogen-activated Protein Kinase-dependent Manner* , 1998, The Journal of Biological Chemistry.

[46]  F. Shibasaki,et al.  Calcineurin functions in Ca(2+)-activated cell death in mammalian cells , 1995, The Journal of cell biology.

[47]  C. Newgard,et al.  Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. , 1992, The Journal of biological chemistry.

[48]  B. McManus,et al.  Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. , 1999, Circulation.

[49]  D. Leroith,et al.  Insulin-like Growth Factor 1 Inhibits Apoptosis Using the Phosphatidylinositol 3′-Kinase and Mitogen-activated Protein Kinase Pathways* , 1997, The Journal of Biological Chemistry.

[50]  J. Romashkova,et al.  NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. , 1999, Nature.

[51]  AnttiSaraste,et al.  Apoptosis in Human Acute Myocardial Infarction , 1997 .